1. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study
- Author
-
Hiroyuki Yamashita, Yuko Takahashi, Hiroshi Kaneko, Saeko Yamada, and Kyoko Motomura
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Immunology ,Malignancy ,Risk Assessment ,Polymyositis ,Dermatomyositis ,03 medical and health sciences ,Sex Factors ,0302 clinical medicine ,Japan ,Rheumatology ,Risk Factors ,Neoplasms ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Humans ,Immunology and Allergy ,030212 general & internal medicine ,Aged ,Retrospective Studies ,030203 arthritis & rheumatology ,business.industry ,Age Factors ,Interstitial lung disease ,Cancer ,Retrospective cohort study ,Odds ratio ,Middle Aged ,Prognosis ,medicine.disease ,Female ,Lung Diseases, Interstitial ,business - Abstract
The objective of this study was to identify factors predictive of malignancy in patients with polymyositis (PM) and dermatomyositis (DM) in Japan. We conducted a retrospective study of PM and DM patients who were admitted to our hospital between January 1992 and September 2017. Among 134 patients, 29 (21.6%) were diagnosed with cancer in the 3 years prior to and 3 years after the initial diagnosis of PM or DM. According to multivariate analyses, male sex [odds ratio (OR) = 3.65, p = 0.03], old age (OR = 1.05, p = 0.02), and a past history of diabetes mellitus (OR = 10.4, p = 0.005) were associated with an increased risk of malignancy. The absence of interstitial lung disease (ILD) (OR = 0.25, p = 0.03) was also associated with an increased risk of malignancy. Diabetes mellitus was observed in 28.6% of PM and DM patients with malignancy, but in only 7.3% of those with malignancy. Survival was significantly lower in patients with malignancy than in those without malignancy (p
- Published
- 2019
- Full Text
- View/download PDF